应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GNPX Genprex, Inc.
已收盘 07-22 16:00:00 EDT
1.97
+0.03
+1.55%
盘后
1.99
+0.02
+0.96%
19:56 EDT
最高
1.98
最低
1.87
成交量
1.40万
今开
1.90
昨收
1.94
日振幅
5.66%
总市值
412.82万
流通市值
410.89万
总股本
209.55万
成交额
2.66万
换手率
0.67%
流通股本
208.57万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Genprex, Inc.盘中异动 临近收盘大幅拉升5.05%报2.08美元
自选股智能写手 · 07-17
Genprex, Inc.盘中异动 临近收盘大幅拉升5.05%报2.08美元
Genprex, Inc.盘中异动 急速拉升5.57%报1.99美元
自选股智能写手 · 07-01
Genprex, Inc.盘中异动 急速拉升5.57%报1.99美元
Genprex, Inc.盘中异动 股价大涨6.32%报2.09美元
自选股智能写手 · 06-28
Genprex, Inc.盘中异动 股价大涨6.32%报2.09美元
Genprex, Inc.盘中异动 早盘快速上涨6.12%
自选股智能写手 · 06-27
Genprex, Inc.盘中异动 早盘快速上涨6.12%
Genprex, Inc.盘中异动 大幅拉升6.13%报2.17美元
自选股智能写手 · 06-26
Genprex, Inc.盘中异动 大幅拉升6.13%报2.17美元
Genprex, Inc.盘中异动 早盘大幅拉升7.92%
自选股智能写手 · 06-24
Genprex, Inc.盘中异动 早盘大幅拉升7.92%
Genprex, Inc.盘中异动 急速下跌5.62%
自选股智能写手 · 06-14
Genprex, Inc.盘中异动 急速下跌5.62%
Genprex, Inc.盘中异动 早盘股价大跌5.12%
自选股智能写手 · 06-07
Genprex, Inc.盘中异动 早盘股价大跌5.12%
Genprex, Inc.盘中异动 早盘急速跳水6.98%
自选股智能写手 · 06-04
Genprex, Inc.盘中异动 早盘急速跳水6.98%
Genprex, Inc.盘中异动 快速下挫5.14%
自选股智能写手 · 06-03
Genprex, Inc.盘中异动 快速下挫5.14%
Genprex, Inc.股价拉升13.22% 市值涨76.02万美元
自选股智能写手 · 05-31
Genprex, Inc.股价拉升13.22% 市值涨76.02万美元
Genprex, Inc.盘中异动 早盘大幅拉升6.60%报2.26美元
自选股智能写手 · 05-29
Genprex, Inc.盘中异动 早盘大幅拉升6.60%报2.26美元
HC Wainwright & Co.:重申Genprex(GNPX.US)评级,由买入调整至买入评级, 目标价10.00美元。
智通财经 · 05-15
HC Wainwright & Co.:重申Genprex(GNPX.US)评级,由买入调整至买入评级, 目标价10.00美元。
Genprex, Inc.盘中异动 股价大跌7.11%报2.22美元
自选股智能写手 · 05-14
Genprex, Inc.盘中异动 股价大跌7.11%报2.22美元
Genprex, Inc.盘中异动 早盘股价大涨9.47%
自选股智能写手 · 05-13
Genprex, Inc.盘中异动 早盘股价大涨9.47%
Genprex, Inc.盘中异动 股价大跌5.35%
自选股智能写手 · 05-10
Genprex, Inc.盘中异动 股价大跌5.35%
Genprex, Inc.盘中异动 早盘股价大跌6.27%
自选股智能写手 · 05-07
Genprex, Inc.盘中异动 早盘股价大跌6.27%
Genprex, Inc.盘中异动 股价大涨5.32%
自选股智能写手 · 05-07
Genprex, Inc.盘中异动 股价大涨5.32%
Genprex, Inc.盘中异动 快速上涨5.31%
自选股智能写手 · 05-03
Genprex, Inc.盘中异动 快速上涨5.31%
Genprex, Inc.盘中异动 早盘股价大涨7.21%
自选股智能写手 · 04-30
Genprex, Inc.盘中异动 早盘股价大涨7.21%
加载更多
公司概况
公司名称:
Genprex, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司,为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司,开发一种新的方法来治疗癌症,根据其新的专利技术平台,包括其最初的候选产品,Oncoprex免疫基因治疗提供,或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因,然后静脉内施用并被肿瘤细胞摄取,其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制,其中断细胞信号通路,其引起癌细胞的复制和增殖,重新建立癌细胞中凋亡途径或程序性细胞死亡途径,并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。
发行价格:
--
{"stockData":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":1.97,"timestamp":1721678400000,"preClose":1.94,"halted":0,"volume":14013,"hourTrading":{"tag":"盘后","latestPrice":1.989,"preClose":1.97,"latestTime":"19:56 EDT","volume":901,"amount":1792.5016,"timestamp":1721692577861},"delay":0,"floatShares":2085725,"shares":2095545,"eps":-18.88218,"marketStatus":"已收盘","marketStatusCode":5,"change":0.03,"latestTime":"07-22 16:00:00 EDT","open":1.9,"high":1.9799,"low":1.87,"amount":26634.8229912,"amplitude":0.056649,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.88218,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721721600000},"adr":0,"listingDate":1522296000000,"adjPreClose":1.94,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.989,"preClose":1.97,"latestTime":"19:56 EDT","volume":901,"amount":1792.5016,"timestamp":1721692577861},"volumeRatio":0.613911,"impliedVol":5.668,"impliedVolPercentile":0.9926},"requestUrl":"/m/hq/s/GNPX","defaultTab":"news","newsList":[{"id":"2452454942","title":"Genprex, Inc.盘中异动 临近收盘大幅拉升5.05%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452454942","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452454942?lang=zh_cn&edition=full","pubTime":"2024-07-17 03:58","pubTimestamp":1721159897,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日03时58分,Genprex, Inc.股票出现异动,股价急速拉升5.05%。截至发稿,该股报2.08美元/股,成交量2.1833万股,换手率1.04%,振幅4.80%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717035817aef9f8d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717035817aef9f8d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2448918011","title":"Genprex, Inc.盘中异动 急速拉升5.57%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448918011","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448918011?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:32","pubTimestamp":1719840732,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时32分,Genprex, Inc.股票出现波动,股价快速拉升5.57%。截至发稿,该股报1.99美元/股,成交量1507股,换手率0.07%,振幅0.00%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213212955f51a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213212955f51a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2446683485","title":"Genprex, Inc.盘中异动 股价大涨6.32%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446683485","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446683485?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:30","pubTimestamp":1719581443,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时30分,Genprex, Inc.股票出现异动,股价急速上涨6.32%。截至发稿,该股报2.09美元/股,成交量317股,换手率0.02%,振幅0.00%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.69%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062821304396817fd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062821304396817fd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2446556870","title":"Genprex, Inc.盘中异动 早盘快速上涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446556870","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446556870?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:44","pubTimestamp":1719495869,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时44分,Genprex, Inc.股票出现波动,股价大幅上涨6.12%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627214430941f1d27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627214430941f1d27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2446399730","title":"Genprex, Inc.盘中异动 大幅拉升6.13%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446399730","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446399730?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:55","pubTimestamp":1719410103,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时55分,Genprex, Inc.股票出现异动,股价快速拉升6.13%。截至发稿,该股报2.17美元/股,成交量7101股,换手率0.34%,振幅1.37%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为1.19%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062621550396817179&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062621550396817179&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2445795074","title":"Genprex, Inc.盘中异动 早盘大幅拉升7.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445795074","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445795074?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:40","pubTimestamp":1719236449,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时40分,Genprex, Inc.股票出现异动,股价急速上涨7.92%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.82%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214049aef6514c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214049aef6514c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2443675825","title":"Genprex, Inc.盘中异动 急速下跌5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443675825","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443675825?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:56","pubTimestamp":1718373408,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时56分,Genprex, Inc.股票出现异动,股价急速下挫5.62%。截至发稿,该股报2.28美元/股,成交量1.0057万股,换手率0.48%,振幅6.20%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614215648af8da292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614215648af8da292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2441069125","title":"Genprex, Inc.盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441069125","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441069125?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:36","pubTimestamp":1717767394,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日21时36分,Genprex, Inc.股票出现异动,股价大幅跳水5.12%。截至发稿,该股报2.60美元/股,成交量3619股,换手率0.17%,振幅2.19%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.05%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607213634aef410ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607213634aef410ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2440523403","title":"Genprex, Inc.盘中异动 早盘急速跳水6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440523403","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440523403?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:44","pubTimestamp":1717512249,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时44分,Genprex, Inc.股票出现波动,股价大幅下挫6.98%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.99%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604224409aef3576b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604224409aef3576b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2440930644","title":"Genprex, Inc.盘中异动 快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440930644","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440930644?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:34","pubTimestamp":1717421647,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时34分,Genprex, Inc.股票出现波动,股价大幅下跌5.14%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.16%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213407941ebe34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213407941ebe34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2439979379","title":"Genprex, Inc.股价拉升13.22% 市值涨76.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439979379","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439979379?lang=zh_cn&edition=full","pubTime":"2024-05-31 21:31","pubTimestamp":1717162315,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日21时31分,Genprex, Inc.股票出现波动,股价快速上涨13.22%。截至发稿,该股报2.74美元/股,成交量25.6598万股,换手率12.23%,振幅4.13%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405312131559f0af78e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405312131559f0af78e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2439576492","title":"Genprex, Inc.盘中异动 早盘大幅拉升6.60%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439576492","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439576492?lang=zh_cn&edition=full","pubTime":"2024-05-29 22:48","pubTimestamp":1716994082,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日22时48分,Genprex, Inc.股票出现异动,股价大幅上涨6.60%。截至发稿,该股报2.26美元/股,成交量9568股,换手率0.46%,振幅6.80%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为1.06%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529224802aef25860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529224802aef25860&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2435903654","title":"HC Wainwright & Co.:重申Genprex(GNPX.US)评级,由买入调整至买入评级, 目标价10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435903654","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435903654?lang=zh_cn&edition=full","pubTime":"2024-05-15 23:34","pubTimestamp":1715787288,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申Genprex(GNPX.US)评级,由买入调整至买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405152334518b0bb259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405152334518b0bb259&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX"],"gpt_icon":0},{"id":"2435519662","title":"Genprex, Inc.盘中异动 股价大跌7.11%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519662","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435519662?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:43","pubTimestamp":1715694230,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时43分,Genprex, Inc.股票出现异动,股价急速跳水7.11%。截至发稿,该股报2.22美元/股,成交量8524股,换手率0.41%,振幅3.35%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514214350861ed1a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514214350861ed1a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2435614375","title":"Genprex, Inc.盘中异动 早盘股价大涨9.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435614375","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435614375?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:54","pubTimestamp":1715608441,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时54分,Genprex, Inc.股票出现波动,股价急速拉升9.47%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为1.15%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513215401876275a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513215401876275a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2434852231","title":"Genprex, Inc.盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434852231","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434852231?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:14","pubTimestamp":1715350462,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时14分,Genprex, Inc.股票出现波动,股价大幅下跌5.35%。截至发稿,该股报2.30美元/股,成交量7144股,换手率0.34%,振幅8.85%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510221423861ec72b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510221423861ec72b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2433097785","title":"Genprex, Inc.盘中异动 早盘股价大跌6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433097785","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433097785?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:04","pubTimestamp":1715090651,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时04分,Genprex, Inc.股票出现波动,股价急速下挫6.27%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.72%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722041287e8620b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722041287e8620b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2433401132","title":"Genprex, Inc.盘中异动 股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433401132","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433401132?lang=zh_cn&edition=full","pubTime":"2024-05-07 00:00","pubTimestamp":1715011203,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日00时00分,Genprex, Inc.股票出现异动,股价大幅上涨5.32%。截至发稿,该股报2.57美元/股,成交量2.5758万股,换手率1.23%,振幅9.02%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050700000387e85ddf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050700000387e85ddf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2432093577","title":"Genprex, Inc.盘中异动 快速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432093577","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432093577?lang=zh_cn&edition=full","pubTime":"2024-05-03 01:55","pubTimestamp":1714672514,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日01时55分,Genprex, Inc.股票出现波动,股价急速上涨5.31%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为1.02%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030155147925b541&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030155147925b541&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2431432594","title":"Genprex, Inc.盘中异动 早盘股价大涨7.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431432594","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431432594?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:34","pubTimestamp":1714484077,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时34分,Genprex, Inc.股票出现异动,股价快速拉升7.21%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。Genprex, Inc.公司简介:Genprex Inc是一家临床阶段的基因治疗公司,专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统,该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021343879258570&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021343879258570&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genprex.com","stockEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":-0.0673},{"period":"3month","weight":-0.0892},{"period":"6month","weight":-0.7679},{"period":"1year","weight":-0.9439},{"period":"ytd","weight":-0.7891}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司,为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司,开发一种新的方法来治疗癌症,根据其新的专利技术平台,包括其最初的候选产品,Oncoprex免疫基因治疗提供,或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因,然后静脉内施用并被肿瘤细胞摄取,其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制,其中断细胞信号通路,其引起癌细胞的复制和增殖,重新建立癌细胞中凋亡途径或程序性细胞死亡途径,并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.912357},{"month":2,"riseRate":0.5,"avgChangeRate":0.15537},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.179543},{"month":4,"riseRate":0.285714,"avgChangeRate":0.230015},{"month":5,"riseRate":0.428571,"avgChangeRate":0.02727},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.121366},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.145307},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032905},{"month":9,"riseRate":0,"avgChangeRate":-0.143387},{"month":10,"riseRate":0,"avgChangeRate":-0.215282},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.138223},{"month":12,"riseRate":0.5,"avgChangeRate":0.020272}],"exchange":"NASDAQ","name":"Genprex, Inc.","nameEN":"Genprex, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Genprex, Inc.,GNPX,Genprex, Inc.股票,Genprex, Inc.股票老虎,Genprex, Inc.股票老虎国际,Genprex, Inc.行情,Genprex, Inc.股票行情,Genprex, Inc.股价,Genprex, Inc.股市,Genprex, Inc.股票价格,Genprex, Inc.股票交易,Genprex, Inc.股票购买,Genprex, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}